Neoplasia/BPH

	A Comparative Study of the Global Burden of Prostate Cancer (1990-2021): Emphasis on the Disparities Between the United States and China. Prostate Li J, Wu Y, Hou J, Liu H, Wang Y, Zhang F, Gu P, Liu X. PMID: 41329033 [PubMed - as supplied by publisher]
	18F-PSMA PET/CT and mpMRI: A combined approach for enhanced risk stratification in prostate cancer-a diagnostic accuracy study. Medicine (Baltimore) Aihemaitijiang M, Zhu H, Che K, Li K, Wumaner A, Li S, Gong H, Shi Z. PMID: 41327708 [PubMed - indexed for MEDLINE]
	Exosomal miRNAs versus circulating tumor DNA: diagnostic accuracy for early detection of recurrence post-radical prostatectomy: A narrative review. Medicine (Baltimore) Bashir H, Afzal MW, Mehmood A, Afzal M, Hassan MW, Parveen A. PMID: 41327686 [PubMed - indexed for MEDLINE]
	Preliminary clinical outcomes of irreversible electroporation in the management of prostatic hyperplasia. Medicine (Baltimore) Yu Z, Wen Q, Guo Y, Chen L, Wang Y, Hang G, Chen B. PMID: 41327666 [PubMed - indexed for MEDLINE]
	Male infertility and the risk of developing prostate cancer: a bidirectional two-sample Mendelian randomization study. Eur J Med Res Shao J, Apizi A, Zheng X, Tao N, An H. PMID: 41327353 [PubMed - as supplied by publisher]
	The impact of androgen deprivation therapy and novel hormonal therapy on thyroid hormone levels in prostate cancer patients: a systematic review and meta-analysis. World J Surg Oncol Chu H, Qu Y. PMID: 41327295 [PubMed - as supplied by publisher]
	Enhancing prediction accuracy for muscle invasion in bladder cancer using a dual-energy CT-based interpretable model incorporating habitat radiomics and deep learning. BMC Cancer Du C, Wei W, Hu M, He J, Shen J, Liu Y, Li J, Liu L. PMID: 41327160 [PubMed - indexed for MEDLINE]
	Preoperative intrinsic capacity phenotypes forecast adverse physical resilience trajectories following surgery in older bladder cancer patients. Eur J Oncol Nurs Liu S, Zheng J, Sun J. PMID: 41325691 [PubMed - as supplied by publisher]
	Comparison of same-day discharge robotic-assisted radical prostatectomy in an ambulatory surgery center versus hospital setting. J Robot Surg Kumar N, Miocinovic R, Beris TD, Goyal M, Bs VK, Patel AR. PMID: 41324771 [PubMed - indexed for MEDLINE]
	Application of three-dimensional Superb micro-vascular imaging (3D-SMI) combined with quantitative blood flow analysis in the noninvasive diagnosis of renal tumors. Ultrasound J Mao Y, Yu C, Wang T, Li F, Hou W, Wei X, Mu J. PMID: 41324744 [PubMed]
	A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer. Clin Cancer Res Medina S, Tokuyama N, Hammouda K, Pathak T, Mirtti T, Fu P, Gupta S, Lal P, Sandler HM, Correa R, Chafe S, Shah A, Efstathiou JA, Hoffman K, Straza M, Hallman MA, Jordan R, Pugh SL, Sweeney CJ, Madabhushi A. PMID: 41324555 [PubMed - as supplied by publisher]
	Automated imaging as an adjunct to serum and clinical biomarkers: a new validated prediction tool for metastatic castration-resistant prostate cancer. Clin Cancer Res Morris MJ, Flynn J, Zhao B, Anand A, Sjöstrand K, Larson SM, Regazzi AM, Borzillo GV, Park A, Schwartz LH, Heller G. PMID: 41324553 [PubMed - as supplied by publisher]
	A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol. Jpn J Clin Oncol Matsumoto T, Tanegashima T, Takeuchi A, Sasaki K, Ogawa G, Kojima T, Kawahara T, Matsui Y, Nishiyama N, Nishiyama H, Kitamura H, Eto M. PMID: 41324490 [PubMed - as supplied by publisher]
	Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2â€‘associated sensitivity in ACHN models. Korean J Physiol Pharmacol Moon J, Vo VTA, Nhat LT, Eom M, Jeong Y. PMID: 41324163 [PubMed - as supplied by publisher]
	Diagnostic accuracy of the Vesical Imaging Reporting and Data System for muscle-invasive bladder cancer and its role in reducing repeat transurethral resection of bladder tumor: A systematic review. Bladder (San Franc) Nandi D, Kumar SK, Hasan A, Kumar V. PMID: 41324075 [PubMed]
	(18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography for bladder cancer staging: Diagnostic accuracy and prognostic implications. Bladder (San Franc) Huynh TNA, Wei X, Arulshankar S, Lam D, Lim KY, Huang J, Rajarubendra N, Chu K, Donnellan S, Ranasinghe W. PMID: 41324069 [PubMed]
	Real-world management of T1 high-grade bladder cancer: A 14-year retrospective single-center study. Bladder (San Franc) Lv Z, Feng Y, Guo B, Jiang B, Zhang H, Lu Y, Gao W, Tang J, Ai Q, Cheng Q, Li H. PMID: 41324068 [PubMed]
	A non-invasive MRI-based multimodal fusion deep learning model (MF-DLM) for predicting overall survival in bladder cancer: a multicentre retrospective study. EClinicalMedicine Cai L, Bai R, Cao Q, Sun W, Wang F, Liu X, Liang B, Jiang M, Wang G, Shao Q, Jiang X, Wang C, Chen C, Tan Z, Wu Q, Bao M, Yu H, Li P, Yang X, Lu Q. PMID: 41324013 [PubMed]
	A head-to-head comparison of sextant-systematic biopsy vs. extended-systematic biopsy for prostate cancer diagnosis in the era of MRI-targeted biopsy: SEXTANT-PRO non-inferiority randomized clinical trial. EClinicalMedicine Deng R, Shang J, Wu J, Tian S, Li D, Shen Q, Hu S, Shang M, Qiu J, Zhou J, Cai L, Gong K, Liu Y. PMID: 41324010 [PubMed]
	A case-based review of urachal carcinoma with mixed small cell neuroendocrine and adenocarcinoma components, with one new case report and analysis of nine published cases. Front Endocrinol (Lausanne) Chu J, Zhai J, Ma Q, Zhang Z, Yuan Y, Yuan H, Wei C, Wang M. PMID: 41323974 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 183573

Page 1 of 9179



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy